Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 16.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors |
| 03.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | rincipal terms of the amendments are described in Item 5.02 below, which description is incorporated by reference into t |
Stammdaten
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Unternehmen & Branche
| Name | ClearPoint Neuro, Inc. |
|---|---|
| Ticker | CLPT |
| CIK | 0001285550 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 309,3 Mio. USD |
| Beta | 1,18 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 36,971,000 | -25,540,000 | -0.90 | 97,747,000 | 28,020,000 |
| 2025-09-30 | 10-Q | 8,861,000 | -5,891,000 | -0.21 | 60,357,000 | 15,874,000 |
| 2025-06-30 | 10-Q | 9,215,000 | -5,837,000 | -0.21 | 62,869,000 | 19,743,000 |
| 2025-03-31 | 10-Q | 8,485,000 | -6,026,000 | -0.22 | 30,070,000 | 19,987,000 |
| 2024-12-31 | 10-K | 31,390,000 | -18,914,000 | -0.70 | 39,189,000 | 25,389,000 |
| 2024-09-30 | 10-Q | 8,122,000 | -4,974,000 | -0.18 | 40,193,000 | 29,001,000 |
| 2024-06-30 | 10-Q | 7,858,000 | -4,408,000 | -0.16 | 52,574,000 | 32,132,000 |
| 2024-03-31 | 10-Q | 7,639,000 | -4,146,000 | -0.16 | 53,637,000 | 34,584,000 |
| 2023-12-31 | 10-K | 23,955,000 | -22,089,000 | -0.90 | 42,661,000 | 21,173,000 |
| 2023-09-30 | 10-Q | 5,762,000 | -4,809,000 | -0.20 | 43,837,000 | 24,094,000 |
| 2023-06-30 | 10-Q | 5,950,000 | -7,052,000 | -0.29 | 47,641,000 | 27,410,000 |
| 2023-03-31 | 10-Q | 5,433,000 | -5,609,000 | -0.23 | 50,247,000 | 32,580,000 |
| 2022-12-31 | 10-K | 20,551,000 | -16,435,000 | -0.68 | 55,490,000 | 36,887,000 |
| 2022-09-30 | 10-Q | 5,146,000 | -3,788,000 | -0.15 | 57,738,000 | 39,878,000 |
| 2022-06-30 | 10-Q | 5,200,000 | -4,303,000 | -0.18 | 60,240,000 | 42,820,000 |
| 2022-03-31 | 10-Q | 5,031,000 | -3,959,000 | -0.17 | 61,768,000 | 45,730,000 |
| 2021-12-31 | 10-K | 16,299,000 | -14,410,000 | -0.69 | 65,581,000 | 48,787,000 |
| 2021-09-30 | 10-Q | 4,574,000 | -3,980,000 | -0.18 | 68,702,000 | 44,120,000 |
| 2021-06-30 | 10-Q | 3,413,000 | -3,743,000 | -0.17 | 72,326,000 | 47,966,000 |
| 2021-03-31 | 10-Q | 4,030,000 | -2,538,000 | -0.13 | 74,263,000 | 43,982,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -19,951 | 15.17 | -302,656.67 | -172,7% | |
| 2026-01-26 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -2,943 | 15.57 | -45,822.51 | -26,1% | |
| 2026-01-09 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -20,000 | 16.12 | -322,400.00 | -183,9% | |
| 2025-10-10 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -1,981 | 28.64 | -56,735.84 | -32,4% | |
| 2025-10-10 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -300 | 29.21 | -8,763.00 | -5,0% | |
| 2025-10-10 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -6,599 | 27.64 | -182,396.36 | -104,0% | |
| 2025-10-10 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -17,583 | 26.51 | -466,125.33 | -265,9% | |
| 2025-06-10 | Richards Timothy T. | Director | Open Market Sale | -10,000 | 13.28 | -132,800.00 | -75,8% | |
| 2025-06-09 | BURNETT JOSEPH | Director, Officer, CEO and President | Open Market Sale | -21,247 | 13.29 | -282,372.63 | -161,1% | |
| 2025-06-03 | FALLON LYNNETTE C | Director | Open Market Sale | -9,000 | 12.53 | -112,770.00 | -64,3% | |
| 2025-06-03 | FALLON LYNNETTE C | Director | Open Market Sale | -1,200 | 12.88 | -15,456.00 | -8,8% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.